Skip to content
← Full study record

NCT01989598 · MORE INFO

Limitations, agreements, and source contact

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2022-03-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Suzanne.Trudel@uhn.ca
organization
Princess Margaret Cancer Centre
phone
4169464501
phone Ext
4566
title
Dr. Suzanna Trudel
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Suzanne.Trudel@uhn.ca
organization
Princess Margaret Cancer Centre
phone
4169464501
phone Ext
4566
title
Dr. Suzanna Trudel

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice